Masaharu Ando

946 total citations
41 papers, 695 citations indexed

About

Masaharu Ando is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Masaharu Ando has authored 41 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 23 papers in Hepatology and 12 papers in Surgery. Recurrent topics in Masaharu Ando's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (12 papers) and Liver Diseases and Immunity (8 papers). Masaharu Ando is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (12 papers) and Liver Diseases and Immunity (8 papers). Masaharu Ando collaborates with scholars based in Japan, United Kingdom and United States. Masaharu Ando's co-authors include Yoshiaki Iwasaki, Yasuhiro Miyake, Tatsuya Toyokawa, Haruhiko Kobashi, Kazuhide Yamamoto, Kohsaku Sakaguchi, Hiroshi Ikeda, Kouichi Takaguchi, Yasushi Shiratori and Yasuyuki Araki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Masaharu Ando

40 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaharu Ando Japan 15 424 403 216 100 75 41 695
Masanori Atsukawa Japan 18 729 1.7× 714 1.8× 213 1.0× 87 0.9× 98 1.3× 85 1.0k
G.A. Makar United States 14 326 0.8× 341 0.8× 265 1.2× 107 1.1× 29 0.4× 33 636
Norio Itokawa Japan 15 336 0.8× 290 0.7× 82 0.4× 56 0.6× 74 1.0× 54 519
John A. Donovan United States 8 280 0.7× 320 0.8× 222 1.0× 23 0.2× 35 0.5× 10 502
Katsuhisa Nakatsuka Japan 14 340 0.8× 338 0.8× 195 0.9× 49 0.5× 51 0.7× 27 577
Anna Baiges Spain 18 644 1.5× 669 1.7× 300 1.4× 26 0.3× 24 0.3× 49 949
L. Bozzola Italy 19 341 0.8× 289 0.7× 463 2.1× 167 1.7× 47 0.6× 33 894
İbrahim Hatemı Türkiye 15 286 0.7× 88 0.2× 141 0.7× 171 1.7× 56 0.7× 78 720
Michel-Henry Mendler France 7 321 0.8× 148 0.4× 146 0.7× 60 0.6× 56 0.7× 9 654
Jurgen Ludwig United States 12 507 1.2× 730 1.8× 517 2.4× 81 0.8× 31 0.4× 12 945

Countries citing papers authored by Masaharu Ando

Since Specialization
Citations

This map shows the geographic impact of Masaharu Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaharu Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaharu Ando more than expected).

Fields of papers citing papers by Masaharu Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaharu Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaharu Ando. The network helps show where Masaharu Ando may publish in the future.

Co-authorship network of co-authors of Masaharu Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Masaharu Ando. A scholar is included among the top collaborators of Masaharu Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaharu Ando. Masaharu Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imagawa, Atsushi, Hiroyuki Sakae, Hitomi Endo, et al.. (2014). A target-controlled infusion system with bispectral index monitoring of propofol sedation during endoscopic submucosal dissection. SHILAP Revista de lepidopterología. 3(1). E2–E6. 10 indexed citations
2.
Moriya, Akio, et al.. (2014). Roles of alcohol consumption in fatty liver: A longitudinal study. Journal of Hepatology. 62(4). 921–927. 76 indexed citations
3.
Miyake, Yasuhiro, Kenichi Harada, Yasuni Nakanuma, et al.. (2014). Overlap of IgG4-related Sclerosing Cholangitis and Primary Biliary Cirrhosis. Internal Medicine. 53(13). 1429–1433. 3 indexed citations
4.
Ikeda, Fusao, Ryoichi Okamoto, Nobuyuki Baba, et al.. (2012). Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. Journal of Gastroenterology and Hepatology. 27(8). 1320–1328. 19 indexed citations
5.
Imagawa, Atsushi, Toshihiro Inokuchi, Takayuki Imada, et al.. (2012). Peppermint Oil Solution Is Useful as an Antispasmodic Drug for Esophagogastroduodenoscopy, Especially for Elderly Patients. Digestive Diseases and Sciences. 57(9). 2379–2384. 17 indexed citations
6.
Matsumoto, Kazuyuki, Yasuhiro Miyake, Hironari Kato, et al.. (2011). Effect of Low-Dose Gemcitabine on Unresectable Pancreatic Cancer in Elderly Patients. Digestion. 84(3). 230–235. 14 indexed citations
7.
Iwasaki, Yoshiaki, Hironori Tanaka, Yasuyuki Araki, et al.. (2010). Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2. Scandinavian Journal of Gastroenterology. 46(1). 79–90. 3 indexed citations
8.
Takahara, Masahiro, Yasuhiro Miyake, Kazuyuki Matsumoto, et al.. (2009). A case of hepatic angiomyolipoma difficult to distinguish from hepatocellular carcinoma. World Journal of Gastroenterology. 15(23). 2930–2930. 11 indexed citations
9.
10.
Miyake, Yasuhiro, Yoshiaki Iwasaki, Haruhiko Kobashi, et al.. (2009). Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood. Hepatology Research. 39(8). 766–771. 5 indexed citations
11.
Miyake, Yasuhiro, Yoshiaki Iwasaki, Haruhiko Kobashi, et al.. (2008). Clinical features of antinuclear antibodies‐negative type 1 autoimmune hepatitis. Hepatology Research. 39(3). 241–246. 17 indexed citations
12.
Miyake, Yasuhiro, et al.. (2008). Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Hepatology Research. 38(10). 980–986. 29 indexed citations
13.
Miyake, Yasuhiro, Yoshiaki Iwasaki, Yasuhiro Makino, et al.. (2007). Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non‐acetaminophen‐related fulminant hepatic failure. Journal of Gastroenterology and Hepatology. 22(6). 855–861. 10 indexed citations
14.
Kobashi, Haruhiko, Shinichi Fujioka, Kozo Fujio, et al.. (2007). A prospective and comparative cohort study on efficacy and drug resistance during long‐term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis. Journal of Gastroenterology and Hepatology. 23(5). 794–803. 24 indexed citations
15.
Toyokawa, Tatsuya, Koichi Izumikawa, Daisuke Kawai, et al.. (2007). [Case report of asymptomatic arteriovenous malformation (AVM) of the pancreas; diagnostic advantage of three-dimensional computed tomography].. PubMed. 104(1). 64–70. 4 indexed citations
16.
Iwasaki, Yoshiaki, Hiroshi Ikeda, Yasuyuki Araki, et al.. (2005). Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C†. Hepatology. 43(1). 54–63. 142 indexed citations
17.
Miyake, Yasuhiro, Kohsaku Sakaguchi, Yoshiaki Iwasaki, et al.. (2005). New Prognostic Scoring Model for Liver Transplantation in Patients with Non-Acetaminophen-Related Fulminant Hepatic Failure. Transplantation. 80(7). 930–936. 23 indexed citations
18.
Iwasaki, Yoshiaki, Kouichi Takaguchi, Hiroshi Ikeda, et al.. (2004). Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy. Liver International. 24(6). 603–610. 50 indexed citations
19.
Ando, Masaharu. (1989). SHADING AND COLOR CORRECTION OF ENDOSCOPIC PICTURES. Acta gastro-enterologica belgica. 31(7). 1727–1741. 1 indexed citations
20.
Tanaka, Ryoji, Tatsuya Itoshima, Toshio Ito, et al.. (1986). Prognostic parameters indicating progression from chronic hepatitis to liver cirrhosis.. Kanzo. 27(3). 317–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masanori Atsukawa Breakdown of academic impact, for papers by G.A. Makar Breakdown of academic impact, for papers by Norio Itokawa Breakdown of academic impact, for papers by John A. Donovan Breakdown of academic impact, for papers by Katsuhisa Nakatsuka Breakdown of academic impact, for papers by Anna Baiges Breakdown of academic impact, for papers by L. Bozzola Breakdown of academic impact, for papers by İbrahim Hatemı Breakdown of academic impact, for papers by Michel-Henry Mendler Breakdown of academic impact, for papers by Jurgen Ludwig
Rankless by CCL
2026